Coronavirus Vaccine? Two Pharmaceutical Giants Collaborating To Develop One
Pharmaceutical companies GSK and Sanofi are partnering to work on several vaccine candidates to fight the coronavirus.
pharmaceutical development
Might The Experimental Drug Remdesivir Work Against COVID-19?
It's too soon to know if the antiviral compound tested in 2014 as a potential Ebola treatment will hobble the coronavirus. Lab tests show promise, but studies in people with COVID-19 have only begun.
Canada's Decision To Make Public More Clinical Trial Data Puts Pressure On FDA
The U.S. Food and Drug Administration treats most data it gets on the development of new drugs and medical devices as confidential to companies. Critics say making the data public would help patients.
Professional 'Guinea Pigs' Can Make A Living Testing Drugs
One man died and five others were injured in a clinical trial in France this year. Trials like those depend on healthy people willing to take experimental medications in return for cash.
High Doses Of Experimental Drug Implicated In Botched French Study
In January, one person died and five others were hospitalized during a test of an experimental drug in western France. Scientists are still trying to figure out exactly what went wrong.
FDA Approval Could Turn A Free Drug For A Rare Disease Pricey
Jacobus Pharmaceutical freely gives its experimental drug to patients with a rare disease. Now a rival wants FDA approval to sell its own version — and expects to charge at least $37,500 per year.
Senate Questions 'Egregious' Price Hikes For Specialty Medicines
Some companies have bought the patents for old drugs, then abruptly upped the prices — from $13 per pill to $750 in one case. Irate senators call it price gouging.
Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs
The cost of medication to treat multiple sclerosis has risen much faster than inflation, even for older drugs. Patients and insurers say manufacturers' subsidy programs have helped, but not enough.
FDA Decision Signals New Competition For Some Of The Costliest Drugs
Drugs made from proteins or antibodies are difficult for rival manufacturers to copy. The Food and Drug Administration just approved a copycat drug for cancer patients that shows it can be done.